TY - JOUR
T1 - Relative wall thickness and the risk for ventricular tachyarrhythmias in patients with left ventricular dysfunction
AU - Biton, Yitschak
AU - Goldenberg, Ilan
AU - Kutyifa, Valentina
AU - Baman, Jayson R.
AU - Solomon, Scott
AU - Moss, Arthur J.
AU - Szepietowska, Barbara
AU - McNitt, Scott
AU - Polonsky, Bronislava
AU - Zareba, Wojciech
AU - Barsheshet, Alon
N1 - Publisher Copyright:
© 2016 American College of Cardiology Foundation.
PY - 2016/1/26
Y1 - 2016/1/26
N2 - Background Relative wall thickness (RWT), defined as 2 times posterior wall thickness divided by the left ventricular (LV) diastolic diameter, is a measure of LV geometry and may be a marker for adverse events in patients with LV dysfunction. Objectives The aim of this study was to investigate the relationship between RWT and the risk for ventricular tachyarrhythmia (VA) in patients enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study. Methods The study population comprised 1,260 patients with mild heart failure and left bundle branch block. Results In a multivariable model, RWT was the most powerful echocardiographic measure for estimating the risk of VAs compared with commonly used echocardiographic variables. Patients with low RWT (<0.24) had 83% (p < 0.001) increased risk for VA and 68% (p < 0.001) increase in VA risk or death (VA/death) compared with patients with higher RWT values. Each 0.01-unit decrease in RWT was associated with 12% (p < 0.001) and 10% (p < 0.001) increases in the risk of VA and VA/death, respectively. Treatment with cardiac resynchronization therapy with defibrillator (CRT-D; CRT with implantable cardioverter-defibrillator) was associated with a greater increase in RWT compared with implantable cardioverter-defibrillator at 12 months (4.6 ± 6.8% vs. 1.5 ± 2.7%; p < 0.001), and every 10% increase in RWT in CRT-D patients was associated with 34% (p = 0.027) and 36% (p = 0.009) reductions in the risk of subsequent VA and VA/death, respectively. Conclusions In patients with mild heart failure and left bundle branch block, decreased RWT was associated with an increase in the risk of VA and VA/death. CRT-D therapy was associated with a favorable increase in RWT and reduction in risk of VA and VA/death.
AB - Background Relative wall thickness (RWT), defined as 2 times posterior wall thickness divided by the left ventricular (LV) diastolic diameter, is a measure of LV geometry and may be a marker for adverse events in patients with LV dysfunction. Objectives The aim of this study was to investigate the relationship between RWT and the risk for ventricular tachyarrhythmia (VA) in patients enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study. Methods The study population comprised 1,260 patients with mild heart failure and left bundle branch block. Results In a multivariable model, RWT was the most powerful echocardiographic measure for estimating the risk of VAs compared with commonly used echocardiographic variables. Patients with low RWT (<0.24) had 83% (p < 0.001) increased risk for VA and 68% (p < 0.001) increase in VA risk or death (VA/death) compared with patients with higher RWT values. Each 0.01-unit decrease in RWT was associated with 12% (p < 0.001) and 10% (p < 0.001) increases in the risk of VA and VA/death, respectively. Treatment with cardiac resynchronization therapy with defibrillator (CRT-D; CRT with implantable cardioverter-defibrillator) was associated with a greater increase in RWT compared with implantable cardioverter-defibrillator at 12 months (4.6 ± 6.8% vs. 1.5 ± 2.7%; p < 0.001), and every 10% increase in RWT in CRT-D patients was associated with 34% (p = 0.027) and 36% (p = 0.009) reductions in the risk of subsequent VA and VA/death, respectively. Conclusions In patients with mild heart failure and left bundle branch block, decreased RWT was associated with an increase in the risk of VA and VA/death. CRT-D therapy was associated with a favorable increase in RWT and reduction in risk of VA and VA/death.
KW - cardiac resynchronization therapy
KW - heart failure
KW - implantable cardioverter-defibrillator
KW - mortality
KW - ventricular fibrillation
KW - ventricular tachycardia
UR - http://www.scopus.com/inward/record.url?scp=84957837319&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2015.10.076
DO - 10.1016/j.jacc.2015.10.076
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26796396
AN - SCOPUS:84957837319
SN - 0735-1097
VL - 67
SP - 303
EP - 312
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 3
ER -